abrdn Life Sciences Investors (NYSE:HQL – Get Free Report) declared a quarterly dividend on Tuesday, November 10th. Stockholders of record on Friday, November 20th will be given a dividend of $1.50 per share on Tuesday, January 12th. This represents a $6.00 dividend on an annualized basis and a dividend yield of 31.7%. The ex-dividend date of this dividend is Friday, November 20th.
abrdn Life Sciences Investors Price Performance
NYSE:HQL traded up $0.26 on Wednesday, hitting $18.93. The company had a trading volume of 77,995 shares, compared to its average volume of 127,762. abrdn Life Sciences Investors has a 52 week low of $15.66 and a 52 week high of $22.67. The firm has a 50 day moving average of $18.62 and a two-hundred day moving average of $18.28.
abrdn Life Sciences Investors Company Profile
abrdn Life Sciences Investors is a non-diversified, closed-end investment fund focused on companies in the life sciences and health care sectors. Rather than developing or selling products itself, the fund invests in businesses involved in areas such as biotechnology, pharmaceuticals, medical devices and related services. The fund seeks long-term capital appreciation through a portfolio that can include both publicly traded and privately held companies. Its investments may span U.S. and international markets.
Further Reading
- Five stocks we like better than abrdn Life Sciences Investors
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for abrdn Life Sciences Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Life Sciences Investors and related companies with MarketBeat.com's FREE daily email newsletter.
